Advertisement
Screener

ACTINIUM PHARMACEUTICALS, INC. (ATNM) Cash

2.8 / 5 stars · 68/120 Roast Me

ACTINIUM PHARMACEUTICALS, INC. Cash

ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Cash of $5.88 million as of 2014-03-31, per its 10-Q filed 2014-05-12.

Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent

us-gaap:Cash · last filed 2014-05-12

  • 2014-03-31: Cash $5.88M.
  • 2013-12-31: Cash $5.53M.
  • 2012-12-31: Cash $5.62M.
  • 2012-09-30: Cash $0.00.
Period endCashCash as first filed
2014-03-31$5.88M
10-Q · filed 2014-05-12
2013-12-31$5.53M
10-Q · filed 2014-05-12
2012-12-31$5.62M
10-K · filed 2014-02-28
2012-09-30$0.00
10-Q · filed 2012-11-14
2012-06-30$142.00
10-Q/A · filed 2012-08-29
2012-03-31$150.00
10-Q · filed 2012-04-23
2011-12-31$5.70M
10-K · filed 2013-03-29
$150.00
10-K · filed 2012-04-12
2011-09-30$150.00
10-Q · filed 2011-11-14
2011-06-30$150.00
10-Q · filed 2011-08-12
2010-12-31$150.00
10-K · filed 2012-04-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
BriaCell Therapeutics Corp. (BCTX)$0.037B
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Incannex Healthcare Inc. (IXHL)$0.040B-22.32